Items tagged “liver mri”
9 results found
Article
Hepatocellular carcinoma
Hepatocellular carcinoma (HCC), also called hepatoma, is the most common primary malignancy of the liver. It is strongly associated with cirrhosis, from both alcohol and viral etiologies. Hepatocellular carcinomas constitute approximately 5% of all cancers partly due to the high endemic rates of...
Article
Giant hepatic hemangioma
Giant hepatic hemangiomas, also known as giant hepatic venous malformations, are relatively uncommon non-neoplastic vascular lesions of the liver, which can be strikingly large and mimic tumors.
Terminology
It is important to note that according to newer nomenclature, these lesions are known ...
Article
Klatskin tumor
Klatskin tumor is a term that was traditionally given to a hilar (perihilar) cholangiocarcinoma, occurring at the bifurcation of the common hepatic duct. Typically, these tumors are small, poorly differentiated, exhibit aggressive biologic behavior, and tend to obstruct the intrahepatic bile duc...
Article
Gadoxetate disodium
Gadoxetate disodium (also known by the tradenames Primovist in Europe and Australia/New Zealand and Eovist in the United States) is a hepatospecific paramagnetic gadolinium-based contrast agent, used exclusively in MRI liver imaging. Its primary use is in hepatic lesion characterization, i.e. as...
Article
Hepatobiliary contrast agents and LI-RADS
LI-RADS (Liver Imaging Reporting and Data System) is both a set of standardized terminology and a classification system for imaging findings in liver lesions. The LI-RADS score for a liver lesion is an indication of its relative risk for hepatocellular carcinoma (HCC). The classification system ...
Article
Hepatocellular carcinoma (surveillance)
Hepatocellular carcinoma surveillance programs have been adopted by some health systems in attempts to effect an early diagnosis of hepatocellular carcinoma in high-risk populations.
Rationale
The idea behind hepatocellular carcinoma screening, as with any screening program, is to detect clin...
Article
Hepatocellular carcinoma (staging)
Hepatocellular carcinoma staging classifications supersede the typical TNM staging system seen in most other epithelial cancers, as the TNM staging system has been found to not be as prognostically useful for stratification of patients with hepatocellular carcinoma. Several substitute staging sy...
Article
Liver cancer (BCLC staging)
Barcelona clinic liver cancer (BCLC) staging uses a set of criteria to guide the management of patients with hepatocellular carcinoma (HCC).
The classification takes the following variables into account 1,2:
performance status (PS)
Child-Pugh score
radiologic tumor extent
tumor size
multi...
Article
Cholangiocarcinoma (staging)
Cholangiocarcinoma staging is most commonly classified using the TNM staging systems of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC), which starting 1 January 2018 is according to its 8th edition. There are separate systems depending on whether the ...
Unable to process the form. Check for errors and try again.